Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population‐Based Cohort Study

Statin use was not associated with ALS survival, suggesting that statins should not routinely be discontinued in ALS.

Authors

Institutions

Publication Details

Journal
European Journal of Neurology
Published
2025-03-01
DOI
https://doi.org/10.1111/ene.70095
Citations
3
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
4.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population‐Based Cohort Study

Hein Stigum, Jesper Dahl, Ola Nakken, Trygve Holmøy et al.
3 citations
European Journal of Neurology
Amyotrophic Lateral Sclerosis Research
4.17
article

Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population‐Based Cohort Study

Hein Stigum, Jesper Dahl, Ola Nakken, Trygve Holmøy, Helmut E. Meyer, Anders Myhre Vaage
article en
3 citations

Abstract

Statin use was not associated with ALS survival, suggesting that statins should not routinely be discontinued in ALS.

European Journal of NeurologyVol. 32(3)
Norwegian Institute of Public Health (NO), University of Oslo (NO), Akershus University Hospital (NO)
Helse Sør-Øst RHF
No poverty, Good health and well-being
Openalex Percentile: Top 7%
Amyotrophic Lateral Sclerosis Research
4.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.